Skip to main content
. 2018 Mar 28;14(6):1361–1373. doi: 10.5114/aoms.2018.74757

Table IV.

Metabolic traits of the samples stratified by genotype

dbSNP Genotype BMI [kg/m2] SBP [mm Hg] DBP [mm Hg] CHOL [mg/dl] Glucose [mg/dl] TRG [mg/dl] HDL [mg/dl] Insulin [mU/ml] HbA1c (%) HOMA-IR
rs10811661 T/T 28 (26–32) 131 (120–148) 76 (68.5–83) 195 (169.5–218) 119 (94–164.5) 171 (127.5–245.5) 39 (34–46) 9 (6–13) 8 (7–10) 2.82 (1.81–4.43)
C/T 28.5 (25–31.75) 135 (121–151) 77 (69–82) 186 (165–214) 122 (97–155) 168 (111–214) 38 (33–44) 5 (4–9) 8 (7–10) 1.74 (0.96–3.88)
C/C 31 (26–33) 137 (120–138) 76 (69–77) 211 (197–217) 150 (141–312) 168 (149–272) 47 (42–51) 4 (3–6) 14 (7–15) 2.22 (1.18–2.38)
P 0.966 0.096 0.988 0.089 0.093 0.08 0.086 0.111 0.133 0.089
rs8192678 C/C 28 (26–31) 132 (120–148) 76 (68–82) 187 (168–216) 121 (95.5–172.5) 169 (125.5–245) 38 (33–45) 7 (4–11) 8 (7–10) 2.28 (140–3.85)
C/T 29 (25.5–32) 134 (123–148) 76 (69–83) 199 (171.5–220.5) 114 (94–150.5) 173 (131–254) 42 (35–49) 10 (7–14) 8 (7–10) 3.00 (1.86–4.68)
T/T 27 (25.5–30.5) 136 (121.5–158.5) 79 (70.5–85) 199 (179.5–224.5) 130 (97–192.5) 156 (128–178) 42 (33–45) 12.5 (8–24.5) 8 (7–10) 4.60 (2.88–6.45)
P 0.651 0.078 0.073 0.063 0.023 0.013 0.087 0.092 0.314 0.065
rs2010963 C/C 29 (26–32) 137 (123.5–148.75) 77 (70–82.75) 183 (164.75–214.75) 128 (97–174.5) 149.5 (109.75–248) 38 (33.75–47.25) 4 (3–9) 8 (7–10) 1.74 (0.97–3.79)
C/G 29 (26–33) 130 (118–147) 74 (67–81) 188 (169–214) 119 (96–168) 169 (127–231) 38 (33–44) 7 (5–11) 8.5 (7–10.75) 2.33 (1.47–3.64)
G/G 28 (25–31) 134.5 (122–148) 76 (69–83) 199 (170.75–224.25) 115.5 (93.75–157) 174 (132.75–252.25) 41 (34.75–49) 10 (7–14) 8 (7–10) 3.05 (1.90–4.90)
P 0.175 0.06 0.012 0.013 0.14 0.081 0.0007* 0.105 0.416 0.09
rs7896005 A/A 28 (25–31) 132 (120–148) 76 (67–80.25) 187.5 (168–215.25) 122 (95–172.25) 168 (122.75–245.25) 38 (33–45) 6 (4–11) 8 (7–11) 2.19 (1.30–3.56)
A/G 28 (26–32) 135 (122.25–147.75) 76 (69–83) 195.5 (168–217.75) 119.5 (96.5–157.75) 174 (131.25–245.5) 39 (34–48.75) 9 (6–13) 8 (7–10) 2.65 (1.79–4.58)
G/G 28 (25–32) 134 (118.5–154) 79 (69.5–86) 203 (182–231) 110 (92.5–166.5) 161 (127–248.5) 42 (35–45) 12 (10–19.5) 8 (6.5–10) 3.72 (2.88–6.33)
P 0.867 0.075 0.012 0.065 0.07 0.051 0.106 0.011 0.592 0.107
rs659366 C/C 29 (26–32) 134.5 (120–148) 76 (68.75–80) 181 (164–216) 117.5 (94.5–156.5) 169.5 (109.75–242) 32 (28–45) 5 (4–10) 8 (7–10) 1.89 (1.14–3.54)
C/T 28 (25–31) 130 (120–147.25) 76 (69–84) 199 (170.5–217) 121 (95.75–175.25) 173 (130–248) 39 (34–46) 8 (5–12) 8 (7–10) 2.68 (1.82–4.17)
T/T 28 (26–32) 136 (123–151) 76 (69–82.5) 199 (177–229) 118 (94–155.5) 165 (128.5–238) 42 (35–49) 11 (7–16) 8 (7–10) 3.11 (2.04–6.16)
P 0.401 0.06 0.634 0.034 0.031 0.028 0.06 0.17 0.286 0.104

dbSNP – the single nucleotide polymorphism database, medians (25–75 percentile), BMI – body max index, SBP – systolic blood pressure, DBP – diastolic blood pressure, CHOL – cholesterol, TRG – triglycerides, HDL – high-density lipoprotein, HbA1c – glycated haemoglobin, HOMA-IR – homeostasis model assessment of insulin resistance. Nominal significance between 0.01 > and < 0.05

*

Significant p-value < 0.01, after Bonferroni correction.